Kestra Advisory Services »

Tg Therapeutics shares owned by Kestra Advisory Services

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Kestra Advisory Services from 13F filings

Historical chart of Kestra Advisory Services investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Kestra Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Kestra Advisory Services

Quarter filed Position value Share count Share price at filing
2023-12-31 $406k 24k 17.08
2023-09-30 $137k 16k 8.36
2023-06-30 $375k 15k 24.84
2023-03-31 $299k 20k 15.04

More positions owned by Kestra Advisory Services

Apple (AAPL)
Parker-Hannifin Corporation (PH)
Ishares Tr Msci Ac Asia Etf (IVV)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Small Cp Etf (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Small Cp Etf (VTI)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl A (BRK.B)
Vanguard Index Fds Small Cp Etf (VUG)
NVIDIA Corporation (NVDA)
First Tr Exchange-traded Rba Indl Etf (RDVY)
Vanguard Index Fds Small Cp Etf (VTV)
Ishares Tr Msci Ac Asia Etf (IJR)

View all positions for Kestra Advisory Services

Top funds holding Tg Therapeutics

Vanguard Group
Darwin Global Management
Millennium Management
Wellington Management Company
Opaleye Management
Paradigm Biocapital Advisors
683 Capital Management
Goldman Sachs Group
Citadel Advisors
Charles Schwab Investment Management
Norges Bank Investment Management
Marshall Wace
Gts Securities
Soleus Capital Management
Jane Street

View all funds holding Tg Therapeutics